Eli Lilly Dealt Another Setback as Lung Cancer Drug Flunks Phase III Test Post author:Sam Post published:October 9, 2017 Post category:BioPharma October 10, 2017By Alex Keown, BioSpace.com Breaking… Source: BioSpace You Might Also Like 5 Biotechs Awaiting FDA Decisions in January 2018 December 27, 2017 Forward Pharma Appeals The Initial Decision In The U.S. Patent Interference To The Federal Circuit May 30, 2017 Aceto Subsidiary, Rising Pharma, Announces Product Launches July 20, 2017
Forward Pharma Appeals The Initial Decision In The U.S. Patent Interference To The Federal Circuit May 30, 2017
